|

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical

RECRUITINGSponsored by Aesculap AG
Actively Recruiting
SponsorAesculap AG
Started2021-07-21
Est. completion2025-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05296889

Summary

Multicenter Post market clinical follow-up Study on the Safety and Performance of Ennovate® Cervical - Prospective, pure data collection of all Ennovate Cervical patients in Total Indications

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patient is minimum 18 years old
* Informed Consent in the documentation of clinical and radiological results
* Patient has indication according to Instructions for Use (IFU)
* Patient is not pregnant

Exclusion Criteria:

* Patient's clear unability or unwillingness to participate in follow-up examinations

Conditions6

CancerDegenerative Disc DiseaseDegenerative MyelopathySpinal InstabilitySpinal TumorSpine Fracture

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.